| 1 |
32688289 | Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy. | 2020 Sep-Oct |
1 |
| 2 |
31306580 | Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma. | 2019 Sep 3 |
1 |
| 3 |
29497956 | Comparison of [99mTc]3PRGD2 Imaging and [18F]FDG PET/CT in Breast Cancer and Expression of Integrin αvβ3 in Breast Cancer Vascular Endothelial Cells. | 2018 Oct |
1 |
| 4 |
29558951 | Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide. | 2018 Mar 20 |
1 |
| 5 |
28004516 | Interaction Mechanism and Clustering among RGD Peptides and Integrins. | 2017 May |
2 |
| 6 |
29053416 | Imaging of Integrin αvβ3 Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer 99mTc-IDA-D-[c(RGDfK)]2. | 2017 Oct |
1 |
| 7 |
26722375 | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3. | 2016 |
1 |
| 8 |
26905697 | Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors. | 2016 Oct |
1 |
| 9 |
26491644 | Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors. | 2015 Oct |
1 |
| 10 |
23796630 | RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia. | 2014 Mar |
1 |
| 11 |
25207865 | Integrin α(V)β(3)-targeted magnetic nanohybrids with enhanced antitumor efficacy, cell cycle arrest ability, and encouraging anti-cell-migration activity. | 2014 Oct 8 |
1 |
| 12 |
23651498 | Imaging of integrin α(V)β(3) expression using (68)Ga-RGD positron emission tomography in pediatric cerebral infarct. | 2013 Jun |
1 |
| 13 |
24206140 | Development of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedside. | 2013 Dec |
2 |
| 14 |
22272823 | A concise review of current radiopharmaceuticals in tumor angiogenesis imaging. | 2012 |
1 |
| 15 |
22455451 | Dual function of RGD-modified VEGI-192 for breast cancer treatment. | 2012 Apr 18 |
1 |
| 16 |
22655084 | Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells. | 2012 |
1 |
| 17 |
22664242 | Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers. | 2012 |
1 |
| 18 |
21447361 | Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. | 2011 Jul 30 |
1 |
| 19 |
21780371 | Magnetic resonance imaging contrast agent: cRGD-ferric oxide nanometer particle and its role in the diagnosis of tumor. | 2011 May |
1 |
| 20 |
19882657 | Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. | 2010 Jan |
1 |
| 21 |
20184307 | Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature. | 2010 Mar 17 |
1 |
| 22 |
19225614 | A photostable fluorescent probe for targeted imaging of tumour cells possessing integrin alpha(v)beta(3). | 2009 Mar |
1 |
| 23 |
19259068 | Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. | 2009 May |
1 |
| 24 |
19360404 | (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. | 2009 Sep |
1 |
| 25 |
19719118 | Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. | 2009 Dec |
1 |
| 26 |
20540537 | (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. | 2009 May 20 |
1 |
| 27 |
17983645 | Mechanisms of nongenomic actions of thyroid hormone. | 2008 May |
1 |
| 28 |
18580570 | In vivo gamma imaging of the secondary tumors of transplanted human fetal striatum neural stem cells-derived primary tumor cells. | 2008 Jul 2 |
1 |
| 29 |
17166537 | Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. | 2007 Feb |
1 |
| 30 |
16418218 | Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. | 2006 Feb 1 |
1 |
| 31 |
17009846 | Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. | 2006 Sep-Oct |
1 |
| 32 |
15898744 | Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization. | 2005 May-Jun |
1 |
| 33 |
22457887 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid) | 2004 |
1 |
| 34 |
22457888 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) | 2004 |
1 |
| 35 |
22457890 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) | 2004 |
1 |
| 36 |
12702756 | Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst. | 2003 Apr 29 |
1 |
| 37 |
14499613 | Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. | 2003 Oct 3 |
1 |
| 38 |
11884718 | Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. | 2002 Apr 5 |
1 |
| 39 |
11676501 | A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesis. | 2001 Nov 2 |
1 |
| 40 |
11779085 | Integrins as targets of angiogenesis inhibition. | 2001 Nov-Dec |
1 |
| 41 |
10773347 | High affinity interactions of Coxsackievirus A9 with integrin alphavbeta3 (CD51/61) require the CYDMKTTC sequence of beta3, but do not require the RGD sequence of the CAV-9 VP1 protein. | 2000 May |
2 |
| 42 |
10998238 | Ligand-integrin alpha v beta 3 interaction determined by photoaffinity cross-linking: a challenge to the prevailing model. | 2000 Sep 12 |
1 |
| 43 |
8636223 | Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3. | 1996 Feb |
1 |
| 44 |
8036014 | Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. | 1994 Aug |
1 |
| 45 |
1717468 | Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha v beta 3 and its ligand. | 1991 Oct 15 |
1 |